Log in to save to my catalogue

Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-w...

Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-w...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8543219

Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence

About this item

Full title

Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence

Publisher

BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd

Journal title

British journal of ophthalmology, 2021-11, Vol.105 (11), p.1475-1479

Language

English

Formats

Publication information

Publisher

BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

The aim of this work was to evaluate the contribution of real-world evidence (RWE) in changing anti-vascular endothelial growth factor (VEGF) therapy treatment practices and improving real-world treatment strategies for neovascular age-related macular degeneration (nAMD).A PubMed literature search was performed to review the large number of English...

Alternative Titles

Full title

Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8543219

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8543219

Other Identifiers

ISSN

0007-1161

E-ISSN

1468-2079

DOI

10.1136/bjophthalmol-2020-317434

How to access this item